Guangzhou Xiangxue Pharmaceutical Co., Ltd. (“Xiangxue”) has expandedits strategic partnership with Athenex, Inc. (Nasdaq: ATNX) to exclusively developand commercialize Athenex’s oncology product candidates Oral Paclitaxel (boththe capsule and the tablet formulations), Oral Irinotecan, as well as...
Source: Guangdong Medical Valley
On October 16, the second award ceremony for the “top 50 biotechnology innovation enterprises in Guangdong-Hong Kong-Macao Greater Bay Area "（“GBA"）was held in Guangzhou. Xiangxue Life Sciences, Ltd (herein after referred to as “XLifes"), a subsidiary of Gua...
BUFFALO, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commer...
Source: MASTVNET （http://www.imastv.com/news/Macao/2019-06-12/334564.html）
Subject：Xiangxue & UM – To Build International Innovation Platform and Demonstration Base of Industrialization For TCM
Cooperating with University of Macau, Xiang...
No. 2, Jinfengyuan Road, Science City,ky棋牌
Guangzhou Economic and Technological Development Zone